Literature DB >> 3157442

Oxygen dependence of hematoporphyrin derivative-induced photoinactivation of Chinese hamster cells.

J B Mitchell, S McPherson, W DeGraff, J Gamson, A Zabell, A Russo.   

Abstract

The oxygen dependence of hematoporphyrin derivative (HPD)-induced photoinactivation of Chinese hamster V79 cells was examined. Cells were treated with HPD (25 micrograms/ml) for 2 h and subsequently exposed to red light (greater than 590 nm) under either aerated or hypoxic (less than 10 ppm O2) conditions. Hypoxic cells were found to be extremely resistant to the lethal effects of HPD and light. The electron-affinic X-ray hypoxic cell sensitizer, SR-2508, did not sensitize hypoxic HPD-treated cells to light. The clinical implications of these findings are discussed, with consideration of the possibility that hypoxic areas in tumors may limit HPD phototherapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157442

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Light-Activated Pharmaceuticals: Mechanisms and Detection.

Authors:  David Kessel; John Reiners
Journal:  Isr J Chem       Date:  2012-09-01       Impact factor: 3.333

Review 2.  Treatment resistance of solid tumors: role of hypoxia and anemia.

Authors:  P Vaupel; O Thews; M Hoeckel
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

3.  Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.

Authors:  Shun Kishimoto; Nobu Oshima; Kazutoshi Yamamoto; Jeeva Munasinghe; Jan Henrik Ardenkjaer-Larsen; James B Mitchell; Peter L Choyke; Murali C Krishna
Journal:  Free Radic Biol Med       Date:  2017-12-29       Impact factor: 7.376

4.  Evaluation of oxygen dependence on in vitro and in vivo cytotoxicity of photoimmunotherapy using IR-700-antibody conjugates.

Authors:  Shun Kishimoto; Marcelino Bernardo; Keita Saito; Sho Koyasu; James B Mitchell; Peter L Choyke; Murali C Krishna
Journal:  Free Radic Biol Med       Date:  2015-04-08       Impact factor: 7.376

5.  Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy.

Authors:  Chenggen Qian; Jicheng Yu; Yulei Chen; Quanyin Hu; Xuanzhong Xiao; Wujin Sun; Chao Wang; Peijian Feng; Qun-Dong Shen; Zhen Gu
Journal:  Adv Mater       Date:  2016-03-07       Impact factor: 30.849

Review 6.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

7.  Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX.

Authors:  L Wyld; J L Burn; M W Reed; N J Brown
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Non-invasive monitoring of photodynamic therapy with 99technetium HMPAO scintigraphy.

Authors:  R B Moore; J D Chapman; A D Mokrzanowski; M R Arnfield; M S McPhee; A J McEwan
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

9.  Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly.

Authors:  Cheng S Jin; Jonathan F Lovell; Juan Chen; Gang Zheng
Journal:  ACS Nano       Date:  2013-02-12       Impact factor: 15.881

10.  The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro.

Authors:  L Wyld; M W Reed; N J Brown
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.